Today: 11 June 2026
Nu Holdings stock dips as Nubank cools off from a 52-week high with U.S. jobs report ahead
7 January 2026
1 min read

Nu Holdings stock dips as Nubank cools off from a 52-week high with U.S. jobs report ahead

New York, January 7, 2026, 09:50 EST — Regular session

Nu Holdings Ltd shares slipped about 2.2% to $17.46 in early New York trade on Wednesday, backing away from recent highs after a strong start to the year.

The pullback comes with the stock still near its 52-week high — the best level in the past year — after a two-session sprint that briefly took it above $18.

Macro data is driving the mood. U.S. private payrolls rose by 41,000 in December, missing forecasts for a 47,000 gain, ADP’s report showed on Wednesday, a day before traders shift attention to Friday’s government jobs data.

Nu jumped 5.4% on Monday to close at $17.94 after touching $18.14, then eased 0.5% on Tuesday even as it hit $18.37, StockAnalysis.com data showed. Turnover cooled as well, with about 59 million shares traded on Tuesday versus roughly 79 million on Monday.

Other U.S.-listed Brazil fintech names were also lower: StoneCo fell about 6% and PagSeguro slid about 1.8% in early trading. In the sector backdrop, Brazilian digital bank PicPay filed for a U.S. IPO on Monday, a reminder that investor appetite for fintech paper has not vanished.

The next U.S. catalyst is close. The Bureau of Labor Statistics is due to release the Employment Situation report for December 2025 at 8:30 a.m. ET on Friday, with the Consumer Price Index for December 2025 set for Jan. 13.

But the setup cuts both ways. A hotter jobs print could push rate expectations and bond yields higher, a mix that can weigh on high-multiple growth stocks; and for digital lenders, any shift in credit quality can move the tape quickly.

Stock Market Today

  • Wall Street Gains on AI Stock Rally Amid Inflation and Middle East Tensions
    June 11, 2026, 11:16 AM EDT. Wall Street recovered some weekly losses Thursday as artificial intelligence (AI) stocks rebounded, led by chipmakers like Marvell Technology (+5.5%), Intel (+7.8%), and Applied Materials (+7.5%). The S&P 500 rose 0.5%, Dow Jones 0.7%, and Nasdaq 0.7%. Despite market gains, concerns about elevated AI valuations persist, while Oracle shares fell 11.1% after revealing plans to raise $40 billion to fund AI investments. Oil prices remained steady despite rising tensions in the Iran conflict, with Brent crude at $92.64 and U.S. crude at $90.29 per barrel. Meanwhile, wholesale inflation in the U.S. exceeded expectations in May, prompting the European Central Bank to raise interest rates, signaling global inflationary pressures.

Latest articles

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

11 June 2026
TOVX soared 74.6% to $0.4252 after Theriva Biologics published Phase 1 VCN-01 data showing survival and biomarker signals in head-and-neck cancer, but the jump was not due to drug approval or revenue; investors face ongoing financing, dilution, and clinical-trial execution risks, with the company’s cash runway only into Q1 2027 and substantial doubt about its ability to continue as a going concern without new capital.
Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

11 June 2026
Trulieve began NYSE trading as TRLV this week after moving from OTC/CSE, authorized a buyback of up to $50 million or 8.5 million shares, and closed its first NYSE session at $11.50, down 0.43%, before trading near $11.78 early Thursday, as investors weigh whether the uplisting and buyback will boost demand amid ongoing federal cannabis policy uncertainty.
Gold price nears record and lifts Newmont stock after hours — what investors watch next
Previous Story

Gold price nears record and lifts Newmont stock after hours — what investors watch next

UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings
Next Story

UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings

Go toTop